Original Article

You have full text access to this OnlineOpen article

Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk

  1. Abul Elahi Ph.D.1,†,
  2. Jean Bendaly M.S.1,†,
  3. Zhong Zheng M.D., Ph.D.1,
  4. Joshua E. Muscat Ph.D., M.P.H.2,
  5. John P. Richie Jr. Ph.D.2,
  6. Stimson P. Schantz M.D.3,
  7. Philip Lazarus Ph.D.1,4,5,‡,*

Article first published online: 1 JUL 2003

DOI: 10.1002/cncr.11587

Issue

Cancer

Cancer

Volume 98, Issue 4, pages 872–880, 15 August 2003

Additional Information

How to Cite

Elahi, A., Bendaly, J., Zheng, Z., Muscat, J. E., Richie, J. P., Schantz, S. P. and Lazarus, P. (2003), Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer, 98: 872–880. doi: 10.1002/cncr.11587

Author Information

  1. 1

    Cancer Epidemiology and Prevention Program, H. Lee Moffitt Cancer Center, Department of Interdisciplinary Oncology, University of South Florida, Tampa, Florida

  2. 2

    Division of Epidemiology and Cancer Susceptibility, American Health Foundation, Valhalla, New York

  3. 3

    Department of Otolaryngology, The New York Eye and Ear Infirmary, New York, New York

  4. 4

    Department of Biochemistry and Molecular Biology, University of South Florida, Tampa, Florida

  5. 5

    Department of Pharmacology and Therapeutics, University of South Florida, Tampa, Florida

  1. †

    Dr. Elahi and Mr. Bendaly contributed equally to this work.

  2. ‡

    Fax: (813) 632-1328

*H. Lee Moffitt Cancer Center, University of South Florida, 12902 Magnolia Drive, MRC-2E, Tampa, FL 33612

Publication History

  1. Issue published online: 1 AUG 2003
  2. Article first published online: 1 JUL 2003
  3. Manuscript Accepted: 19 MAY 2003
  4. Manuscript Revised: 13 MAY 2003
  5. Manuscript Received: 10 APR 2003

Funded by

  • Public Health Service (PHS). Grant Numbers: DE12206, DE13158
  • National Institutes of Health and Human Services. Grant Number: CA68384

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (446K)

REFERENCES

  • 1
    Nowell SA, Massengill JS, Williams S, et al. Glucuronidation of 2-hydroxyamino-1-methy-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis. 1999; 6: 1108–1114.
  • 2
    Tephly TR, Burchell B. UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol Sci. 1990; 11: 276–279.
  • 3
    Gueraud F, Paris A. Glucuronidation: a dual control. Gen Pharmacol. 1998; 31: 683–688.
  • 4
    Ren Q, Murphy SE, Zheng Z, Lazarus P. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. Drug Metab Dispos. 2000; 28: 1352–1360.
  • 5
    MacKenzie PI, Owens IS, Burchell B, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 1997; 7: 255–269.
  • 6
    Owens IS, Ritter JK. Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. Prog Nucleic Acid Res Mol Biol. 1995; 51: 305–338.
  • 7
    Jin CJ, Miners JO, Burchell B, Mackenzie PI. The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis. 1993; 14: 2637–2639.
  • 8
    Grove AD, Kessler FK, Metz RP, Ritter JK. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J Biol Chem. 1997; 272: 1621–1627.
  • 9
    Mojarrabi B, Mackenzie PL. Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. Biochem Biophys Res Commun. 1998; 247: 704–709.
  • 10
    Strassburg CP, Strassburg A, Nguyen N, Li Q, Manns MP, Tukey RH. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem J. 1999; 338: 489–498.
  • 11
    Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics. 2000; 10: 629–644.
  • 12
    Strassburg CP, Manns MP, Tukey RH. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem. 1998; 273: 8719–8726.
  • 13
    Strassburg CP, Nguyen N, Manns MP, Tukey RH. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol. 1998; 54: 647–654.
  • 14
    Strassburg CP, Kneip S, Topp J, et al. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem. 2000; 275: 36164–36171.
  • 15
    Zheng Z, Fang JL, Lazarus P. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos. 2002; 30: 397–403.
  • 16
    Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997; 6: 733–743.
  • 17
    Lazarus P, Park JY. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol. 2000; 36: 421–431.
  • 18
    Ciotti M, Marrone A, Potter C, Owens IS. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics. 1997; 7: 485–495.
  • 19
    Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, Hum DW. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 1997; 7: 317–325.
  • 20
    Levesque E, Beaulieu M, Hum DW, Belanger A. Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 1999; 9: 207–216.
  • 21
    Coffman BL, King CD, Rios GR, Tephly TR. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y (268) and UGT2B7H (268). Drug Metab Dispos. 1998; 6: 73–77.
  • 22
    Macleod SL, Nowell S, Plaxco J, Lang NP. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol. 2000; 7: 777–782.
  • 23
    Huang CS, Luo GA, Hwang MC, Yu SC, Yang SS. Variation of the bilirubin uridine-diphosphogluguronosyltransferase 1A gene in healthy Taiwanese. Pharmacogenetics. 2000; 10: 539–544.
  • 24
    Burchell B, Hume R. Molecular genetic basis of Gilbert's syndrome [review]. J Gastroenterol Hepatol. 1999; 14: 960–966.
    Direct Link:
  • 25
    Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000; 60: 950–956.
  • 26
    Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P. The tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk in Caucasians and African Americans. J Natl Cancer Inst. 2001; 93: 1411–1418.
  • 27
    Vogel A, Kneip S, Barut A, et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology. 2001; 121: 1136–1144.
  • 28
    Fang JL, Beland FA, Doerge DR, et al. Characterization of benzo[a]pyrene-7,8-dihydrodiol glucuronidation by human liver microsomes and over-expressed human UDP-glucuronosyltransferase enzymes. Cancer Res. 2002; 62: 1978–1986.
  • 29
    Richie JP Jr., Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in black and white smokers. Cancer Epidemiol Biomarkers Prev. 1997; 6: 783–790.
  • 30
    Park JY, Muscat J, Schantz S, Stern JC, Lazarus P. Association between GSTM polymorphisms and risk for oral cancer in African Americans as compared to Caucasians. Pharmacogenetics. 2000; 10: 123–131.
  • 31
    Elahi A, Zheng Z, Park JY, Eyring K, McCaffrey T, Lazarus P. The human oxoguanine glycosylase 1 (hOGG1) DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis. 2002; 23: 1229–1234.
  • 32
    Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2002; 10: 1239–1248.
  • 33
    Benhamou S, Benhamou E, Flamant R. Lung cancer risk associated with cigar and pipe smoking. Int J Cancer. 1986; 37: 825–829.
    Direct Link:
  • 34
    National Center for Biotechnology Information. GenBank [database online]. Available from URL: http://www.ncbi.nlm.nih.gov/Genbank/index.html [accessed November 2002]
View Full Article (HTML) Get PDF (446K)